TCL Archive UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says September 24, 1999
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014
TCL Archive ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies May 2, 2003